Sales 0% vs ABGSCe, organic growth of -4%
Adj. EBITA -16% vs ABGSCe, -26% vs FactSet cons.
We expect cons. to lower estimates some 5-8%
Q2’22 outcome
Sales came in at SEK 190m (0% vs ABGSC 190m), Gross profit SEK 110m (+5% vs ABGSC 105m), Adj. EBITA SEK 24m (-16% vs ABGSC 29m), EBIT SEK 17m (-31% vs ABGSC 25m), Net profit SEK 2m (-88% vs ABGSC 17m), EPS SEK 0.1 (-88% vs ABGSCe 0.8). All in all, the report came in-line with top line but showed a lower margin than anticipated, coming in -16% vs ABGSCe and -26% vs FactSet consensus.
LÄS MER
